![]() BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | |||
Founding Date | Founding Date 1929 | Founding Date 1997 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 5,358 | Employees 3,0015% increase | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 10.2 b | Valuation ($) 13.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods €659.1m (FY, 2025) | Cost of goods $717.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €3.3b (FY, 2025) | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income €445.1m (FY, 2025) | Net income $348.9m (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Patent Applications | Patent Applications N/A | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) |

BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company